MId-Day Losers From December 4: Kindred Biosciences, Barnes & Noble, Aeropostale
Kindred Biosciences Inc (NASDAQ: KIN) -30% - Late Wednesday the company announced plans to stop its Atokin Study. Following the announcement Leerink Swann analysts downgraded the stock.
Christopher & Banks Corporation (NYSE: CBK) -27% - Despite beating EPS estimates, the company reported that same-store sales were down 7.6 percent. In addition, the company offered weaker-than-expected guidance.
Aeropostale Inc (NYSE: ARO) -26% - The company reported downbeat earnings and offered weak guidance. Moreover, Morgan Stanley analysts commented on the company saying “Aeropostale will never be debt free again.”
Barnes & Noble, Inc. (NYSE: BKS) -6.7% - Shares are lower following the company’s second-quarter results, missing EPS estimates by a large margin.
ANI Pharmaceuticals Inc (NASDAQ: ANIP) -7.5% - The company announced a $100 million offering of convertible notes.
See more from Benzinga
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
